Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.

Hsu HC, Lapke N, Chen SJ, Lu YJ, Jhou RS, Yeh CY, Tsai WS, Hung HY, Hsieh JC, Yang TS, Thiam TK, You JF.

Cancers (Basel). 2018 Sep 6;10(9). pii: E314. doi: 10.3390/cancers10090314.

2.

Targeted Sequencing of Circulating Tumor DNA to Monitor Genetic Variants and Therapeutic Response in Metastatic Colorectal Cancer.

Hsu HC, Lapke N, Wang CW, Lin PY, You JF, Yeh CY, Tsai WS, Hung HY, Chiang SF, Chen HC, Chen SJ, Hsu A, Yang TS.

Mol Cancer Ther. 2018 Oct;17(10):2238-2247. doi: 10.1158/1535-7163.MCT-17-1306. Epub 2018 Jul 11.

PMID:
29997152
3.

Pazopanib Sensitivity in a Patient With Breast Cancer and FGFR1 Amplification.

Cheng FT, Ou-Yang F, Lapke N, Tung KC, Chen YK, Chou YY, Chen SJ.

J Natl Compr Canc Netw. 2017 Dec;15(12):1456-1459. doi: 10.6004/jnccn.2017.7030.

PMID:
29223982
4.

Prevalence and clinical significance of BRCA1/2 germline and somatic mutations in Taiwanese patients with ovarian cancer.

Chao A, Chang TC, Lapke N, Jung SM, Chi P, Chen CH, Yang LY, Lin CT, Huang HJ, Chou HH, Liou JD, Chen SJ, Wang TH, Lai CH.

Oncotarget. 2016 Dec 20;7(51):85529-85541. doi: 10.18632/oncotarget.13456.

5.

Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.

Lapke N, Lu YJ, Liao CT, Lee LY, Lin CY, Wang HM, Ng SH, Chen SJ, Yen TC.

Oncotarget. 2016 Jul 12;7(28):44194-44210. doi: 10.18632/oncotarget.9925.

6.

The application of anti-Toso antibody enhances CD8(+) T cell responses in experimental malaria vaccination and disease.

Lapke N, Tartz S, Lee KH, Jacobs T.

Vaccine. 2015 Nov 27;33(48):6763-70. doi: 10.1016/j.vaccine.2015.10.065. Epub 2015 Oct 25.

PMID:
26597034

Supplemental Content

Support Center